Emmaus Life Sciences, Inc. Common Stock Shares Outstanding

• Emmaus Life Sciences, Inc. showed an increase of +9.9% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Emmaus Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2011 to 2025), Emmaus Life Sciences, Inc.'s Common Stock Shares Outstanding has grown by 3,650.7%.
• Historical annual values: Fiscal year 2025: 70.19 million shares | Fiscal year 2024: 63.87 million shares | Fiscal year 2023: 61.85 million shares | Fiscal year 2022: 49.58 million shares | Fiscal year 2021: 49.31 million shares | Fiscal year 2020: 48.99 million shares | Fiscal year 2019: 48.47 million shares | Fiscal year 2019: 47.67 million shares | Fiscal year 2018: 37.34 million shares | Fiscal year 2018: 7.41 million shares | Fiscal year 2017: 4.30 million shares | Fiscal year 2016: 1.94 million shares | Fiscal year 2015: 512,405 shares | Fiscal year 2014: 101.67 million shares | Fiscal year 2013: 92.72 million shares | Fiscal year 2012: 1.91 million shares | Fiscal year 2011: 1.87 million shares.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026